Transforming Growth Factor Beta Receptor 2 (TGFBR2) Promoter Region Polymorphisms May Be Involved in Mandibular Retrognathism

被引:8
|
作者
Kirschneck, Margarita [1 ]
Zbidat, Nermien [1 ]
Paddenberg, Eva [1 ]
Reis, Caio Luiz Bitencourt [2 ]
Madalena, Isabela Ribeiro [3 ,4 ,5 ]
de Menezes-Oliveira, Maria Angelica Hueb [6 ]
Lepri, Cesar Penazzo [6 ]
Proff, Peter [1 ]
Kirschneck, Christian [1 ]
Kuechler, Erika Calvano [1 ]
机构
[1] Univ Regensburg, Dept Orthodont, Regensburg, Germany
[2] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Pediat Dent, Ribeirao Preto, Brazil
[3] Univ Regiao Joinville, Dept Dent, Joinville, Brazil
[4] Presidente Tancredo Almeida Neves Univ Ctr, Sch Dent, Sao Joao Del Rei, Brazil
[5] Univ Fed Juiz de Fora, Sch Dent, Dept Restorat Dent, Juiz De Fora, Brazil
[6] Sch Dent Uberaba, Dept Masters Program Dent, Uberaba, Brazil
关键词
GENE POLYMORPHISMS; DIFFERENTIATION; MUTATIONS; DELETION; DEFECTS;
D O I
10.1155/2022/1503052
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Skeletal malocclusions are common phenotypes in humans and have a strong influence on genetic factors. Transforming growth factor beta (TGF beta) controls numerous functions of the human body, including cell proliferation, differentiation, and migration. Thus, this study is aimed at evaluating whether genetic polymorphisms in TGFB1 and its receptor TGFBR2 are associated with mandibular retrognathism in German children and adolescents. Children and teenagers older than 8 years in the mixed or permanent dentition were included in this study. Patients with syndromes and facial trauma and patients with congenital alterations were excluded. Digital cephalometric tracings were performed using the anatomical landmarks point A, point B, sella (S), and nasion (N). Patients that have a retrognathic mandible (SNB < 78 & DEG;) were selected as case group, and the patients with an orthognathic mandible (SNB=78 & DEG;- 82 & DEG;) were selected as the control group. Genomic deoxyribonucleic acid (DNA) from saliva was used to evaluate four genetic polymorphisms in TGFB1 (rs1800469 and rs4803455) and TGBR2 (rs3087465 and rs764522) using real-time PCR. Chi-square or Fisher exact tests were used to compare gender, genotype, and allele distribution among groups. Genotype distribution was calculated in an additive and recessive model. Haplotype analysis was also performed. The established alpha of this study was 5%. A total of 146 patients (age ranging from 8 to 18 years) were included in this epidemiological genetic study. The genetic polymorphism rs3087465 in TGFBR2 was associated with mandibular retrognathism. Carrying the AA genotype in the rs3087465 polymorphism decreased the chance of having mandibular retrognathism (odds ratio=0.25, confidence interval 95%=0.06 to 0.94, p=0.045). None of the haplotypes was associated with mandibular retrognathism (p > 0.05). In conclusion, we found that the genetic polymorphism rs3087465 in the promoter region of the TGFBR2 was associated with mandibular retrognathism in Germans.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Coding DNA Microsatellite Length Within Transforming Growth Factor Beta Receptor 2 (TGFBR2) and Activin Receptor 2 (ACVR2) Determines Frameshift Mutation Rate in Defective DNA Mismatch Repair (MMR)
    Chung, Heekyung
    Lopez, Claudia G.
    Holmstrom, Joy
    Young, Dennis J.
    Lai, Jenny
    Ream-Robinson, Deena
    Carethers, John M.
    GASTROENTEROLOGY, 2010, 138 (05) : S563 - S563
  • [22] Integrative Network Analysis Combined with Quantitative Phosphoproteomics Reveals Transforming Growth Factor-beta Receptor type-2 (TGFBR2) as a Novel Regulator of Glioblastoma Stem Cell Properties
    Narushima, Yuta
    Kozuka-Hata, Hiroko
    Koyama-Nasu, Ryo
    Tsumoto, Kouhei
    Inoue, Jun-ichiro
    Akiyama, Tetsu
    Oyama, Masaaki
    MOLECULAR & CELLULAR PROTEOMICS, 2016, 15 (03) : 1017 - 1031
  • [23] Determination of mutation frequency and rate of activin receptor 2 (Acvr2) and transforming growth factor receptor 2 (Tgfbr2) in colorectal cells with different DNA mismatch repair (MMR) defects
    Chung, Heekyung
    Young, Dennis J.
    Le, Thuy-Anh T.
    Lee, Jeffrey K.
    Ream-Robinson, Deena
    Carethers, John M.
    GASTROENTEROLOGY, 2008, 134 (04) : A113 - A113
  • [24] TGFBR2 mediated phosphorylation of BUB1 at Ser-318 is required for transforming growth factor-β signaling
    Nyati, Shyam
    Gregg, Brandon
    Xu, Jiaqi
    Young, Grant
    Kimmel, Lauren
    Mukesh, Nyati
    Ray, Dipankar
    Yu, Hongtao
    Rehemtulla, Alnawaz
    CANCER RESEARCH, 2019, 79 (13)
  • [25] TGFBR2 mediated phosphorylation of BUB1 at Ser-318 is required for transforming growth factor-β signaling
    Nyati, Shyam
    Gregg, Brandon S.
    Xu, Jiaqi
    Young, Grant
    Kimmel, Lauren
    Nyati, Mukesh K.
    Ray, Dipankar
    Speers, Corey
    Rehemtulla, Alnawaz
    NEOPLASIA, 2020, 22 (04): : 163 - 178
  • [26] Transforming Growth Factor Beta Receptor 3 (TGFBR3)-Associated Membranous Nephropathy
    Caza, Tiffany N.
    Hassen, Samar, I
    Kenan, Daniel J.
    Storey, Aaron
    Arthur, John M.
    Herzog, Christian
    Edmondson, Rick D.
    Bourne, T. David
    Beck, Laurence H., Jr.
    Larsen, Christopher P.
    KIDNEY360, 2021, 2 (08): : 1275 - 1286
  • [27] miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer (vol 10, e0130194, 2015)
    Li, Jialu
    Liang, Hongwei
    Bai, Ming
    Ning, Tao
    Wang, Cheng
    Fan, Qian
    Wang, Yanbo
    Fu, Zheng
    Wang, Nan
    Liu, Rui
    Zen, Ke
    Zhang, Chen-Yu
    Chen, Xi
    Ba, Yi
    PLOS ONE, 2015, 10 (12):
  • [28] If ineffective levels of transforming growth factors and their receptor account for old age being a risk factor for Alzheimer's disease, then increasing TGFBR2 might be therapeutic
    Fessel, Jeffrey
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2020, 6 (01)
  • [29] Defective expression of transforming growth factor P type II receptor (TGFBR2) in the large cell variant of non-small cell lung carcinoma
    Xu, Ji-Bin
    Bao, Yang
    Liu, Xiaohong
    Liu, Yanling
    Huang, Shengdong
    Wang, Jiu-Cun
    LUNG CANCER, 2007, 58 (01) : 36 - 43
  • [30] Two novel polymorphisms in the human transforming growth factor beta 2 gene
    A Alansari
    AH Hajeer
    A Bayat
    S Eyre
    D Carthy
    WER Ollier
    Genes & Immunity, 2001, 2 : 295 - 296